Sign In to Follow Application
View All Documents & Correspondence

Animal Model Expressing Luciferase Under Control Of The Myelin Basic Protein Promoter (Mbp Luci) And Use Of The Model For Bioluminescence In Vivo Imaging

Abstract: A Myelin Basic Protein-luciferase bioimaging noninvasive model to visualize and quantify demyelination and remyelination events in the CNS at transcriptional level in vivo is provided. Luciferase-expressing transgenic animals were generated with myelin basic protein (MBP) promoter coupled to firefly luciferase reporter. The MBP-luci bioimaging model provides a means to monitor myelination status and the efficacy of a remyelination modulating test compound. An advantage of bioimaging is that a subject in a longitudinal study can serve as its own control. The same subject can be tracked over a demyelination and remyelination process continuously over a period of at least 10 weeks. This model enables normalization of individual animal imaging response and provides quality data with considerably reduced variance  In addition  because cohorts of animals need not be sacrificed at different time points  reduction in the number necessary for a compound efficacy study is possible.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
14 June 2012
Publication Number
43/2013
Publication Type
INA
Invention Field
NO SUBJECT
Status
Email
Parent Application

Applicants

SANOFI
54  rue La Boétie  75008  Paris

Inventors

1. CAO  James
c/o Sanofi-aventis U.S.  1041 Route 202-206  Mail Code: BWD-303A  Bridgewater  NJ 08807
2. CHANDROSS  Karen
c/o Sanofi-aventis U.S.  1041 Route 202-206  Mail Code: BWD-303A  Bridgewater  NJ 08807
3. ECONOMIDES  Kyriakos  D.
c/o Sanofi-aventis U.S.  1041 Route 202-206  Mail Code: BWD-303A  Bridgewater  NJ 08807
4. POLITES  Harry Gregory
c/o Sanofi-aventis U.S.  1041 Route 202-206  Mail Code: BWD-303A  Bridgewater  NJ 08807
5. WEINSTOCK  Daniel
c/o Sanofi-aventis U.S.  1041 Route 202-206  Mail Code: BWD-303A  Bridgewater  NJ 08807
6. YING  Xiaoyou
c/o Sanofi-aventis U.S.  1041 Route 202-206  Mail Code: BWD-303A  Bridgewater  NJ 08807

Specification

please see the attachment

Documents

Application Documents

# Name Date
1 5224-CHENP-2012-AbandonedLetter.pdf 2018-07-04
1 Form-5.pdf 2012-06-26
2 5224-CHENP-2012-FER.pdf 2017-12-20
2 Form-3.pdf 2012-06-26
3 Form-18(Online).pdf 2013-12-09
3 Form-1.pdf 2012-06-26
4 5224-CHENP-2012 CORRESPONDENCE OTHERS. 20-07-2012.pdf 2012-07-20
4 5224-CHENP-2012 CORRESPONDENCE OTHERS 01-11-2013.pdf 2013-11-01
5 5224-CHENP-2012 POWER OF ATTORNEY 20-07-2012.pdf 2012-07-20
5 5224-CHENP-2012 FORM-3 14-12-2012.pdf 2012-12-14
6 5224-CHENP-2012 CORRESPONDENCE OTHERS 14-12-2012.pdf 2012-12-14
7 5224-CHENP-2012 POWER OF ATTORNEY 20-07-2012.pdf 2012-07-20
7 5224-CHENP-2012 FORM-3 14-12-2012.pdf 2012-12-14
8 5224-CHENP-2012 CORRESPONDENCE OTHERS 01-11-2013.pdf 2013-11-01
8 5224-CHENP-2012 CORRESPONDENCE OTHERS. 20-07-2012.pdf 2012-07-20
9 Form-1.pdf 2012-06-26
9 Form-18(Online).pdf 2013-12-09
10 Form-3.pdf 2012-06-26
10 5224-CHENP-2012-FER.pdf 2017-12-20
11 Form-5.pdf 2012-06-26
11 5224-CHENP-2012-AbandonedLetter.pdf 2018-07-04

Search Strategy

1 5224chenp2012ss_19-12-2017.pdf